Results
eNauka >
Rezultati >
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
| Naziv: | Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial | Autori  : | Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S.   ; ...; (broj koautora 23) |
Godina: | 2021 | Publikacija: | The Lancet. Oncology | ISSN: | 1470-2045 Lancet Oncology Pretraži identifikator |
Izdavač: | London : Lancet Pub. Group | Tip rezultata: | Naučni članak | Kolacija: | vol. 22 br. 6 str. 801-812 | DOI: | 10.1016/S1470-2045(21)00128-5 | WoS-ID: | 000657432100048 | Scopus-ID: | 2-s2.0-85107139896 | PMID: | 34087126 | URI: | https://enauka.gov.rs/handle/123456789/822958 | URL: | https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00128-5/abstract | Projekat: | European Myeloma Network Janssen Research and Development |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.